LA Billionaire's Biotech Firm Inks With Alexandria

Alexandria Real Estate Equities strikes again. This time, in the former Novartis space in its Nautilus campus.

NantKwest Inc inked a deal for 44,700 SF at 3530 John Hopkins Ct, part of the complex once used by Merck & Co and Novartis, according to filings with the SEC. Alexandria, which bought the Nautilus project in 2012 and renovated into a life science complex, inked the sizable deal with NantKwest this past summer for both office and R&D uses, according to docs.

This deal is part of what Alexandria's Dan Ryan recently called the best leasing quarter in 20 years. The firm also secured a build-to-suit with Eli Lilly at its Campus Point Drive project. This deal for NantKwest comes on the heels of that biotech's recent IPO, which secured a market cap of more than $2B. NantKwest, controlled by LA billionaire Patrick Soon-Shiong (here), makes cancer immunotherapy medicines.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's San Diego Newsletters
Related Stories

JVP Development Is Betting $37M Of Its Own Money That Frisco Is Ready For Spec Office

Hedge Fund Bids $88M For Spirit Airlines' Former HQ

Oyster Point's Second Phase Half-Leased As Kilroy Navigates Soft Lab Demand

BXP Closes In On Next D.C. Office Development As It Shrinks Assets

Clarion Under Contract To Sell 18-Story Seaport Office Tower

Oil Company Expands Again At Cash Register Building

BXP's 343 Madison Lands $1.2B Loan, Nears Deal With Equity Partner

D.C. Sues To Block HUD Headquarters Move To Virginia

Ken Griffin Completes Takeover Of Brickell Block, Setting Stage For $2.5B Megaproject

Private Equity Firm Buys Former Texas Instruments Campus For New Headquarters

DFW Office Footprints Likely To Shrink As AI Use Increases And Companies Battle For Talent

Boston Waterfront Property Planned For Hotel Project Put Up For Sale